Target intelligence / Profile preview

Bordetella pertussis toxin and adhesin virulence factors (None is universally used for the group as a whole. Specific members have abbreviations (e.g., PTX for pertussis toxin, FHA for filamentous hemagglutinin, PRN for pertactin, FIM for fimbriae), but there is no standard collective abbreviation.)

Target
None is universally used for the group as a whole. Specific members have abbreviations (e.g., PTX for pertussis toxin, FHA for filamentous hemagglutinin, PRN for pertactin, FIM for fimbriae), but there is no standard collective abbreviation.
Molecular classification
Toxin (e.g., Pertussis toxin [PTX], adenylate cyclase toxin, dermonecrotic toxin, tracheal cytotoxin), Adhesin (e.g., Filamentous hemagglutinin [FHA], pertactin, fimbriae), Other (This category encompasses structurally diverse proteins including enzymes, membrane-associated proteins, and surface-exposed immunogens)
01

Overview

Bordetella pertussis toxins and adhesins are a set of structurally and functionally distinct proteins produced by the bacterium B. pertussis, the causative agent of whooping cough. The toxins include pertussis toxin (a multi-subunit ADP-ribosylating AB toxin that disrupts immune and cellular signaling), adenylate cyclase toxin (increases cAMP in host cells to inhibit phagocyte function), tracheal cytotoxin (causes tissue damage), and dermonecrotic toxin. The major adhesins include filamentous hemagglutinin, pertactin, and fimbriae, which mediate attachment of the bacterium to host ciliated respiratory epithelial cells. Coordinated regulation and expression of these factors enable successful colonization, immune evasion, and pathogenesis. Inactivated or detoxified versions are major protective antigens in current acellular pertussis vaccines[2][3][4][6]. Note: For future structuring, it is recommended to create individual entries for each major molecule (e.g., "Pertussis toxin," "Filamentous hemagglutinin," "Pertactin," etc.) to better fit canonical target data conventions.

Other names
B. pertussis virulence factorsPertussis toxins and adhesins
02

Mechanism of action

Vaccine-induced immune neutralization: Antibodies generated against PTX, FHA, PRN, or FIM prevent their interaction with host cells, neutralize their function, and reduce bacterial colonization and toxicity. Passive immunization: Experimental, via anti-toxin antibodies

03

Biological functions

Immune modulation and immune evasion (toxins disrupt host immune signaling, e.g., by ADP-ribosylation of G-proteins)Adhesion to host cells (adhesins mediate binding to ciliated epithelial cells of the respiratory tract)Facilitation of colonization and infection (coordinated action of adhesins and toxins)Disruption of cellular signaling (especially by PTX and adenylate cyclase toxin)Cytotoxicity and tissue damage (tracheal cytotoxin, dermonecrotic toxin)Immune stimulation (components serve as vaccine antigens)
04

Disease associations

Infection (specifically, pertussis/whooping cough)Other: Secondary bacterial or viral superinfection by impairment of airway defenses
05

Safety considerations

Antigenic variation in adhesins and toxins may affect vaccine efficacyIncomplete protection (current acellular vaccines sometimes fail to prevent colonization and transmission)Potential for immune evasion and re-emergence of pertussis due to changes in circulating B. pertussis strainsAdverse reactions or toxicity if whole-cell or inadequately detoxified toxoids are used
06

Interacting drugs

Acellular pertussis vaccines (containing inactivated or detoxified toxoids and adhesins)

1 more in the full profile.

07

Biomarkers

Antibodies to pertussis toxin are widely used as markers of infection or vaccine responseAntibodies to FHA, PRN, and FIM also used as immunological markers for exposure or immunization effectiveness

Beyond the preview

Go deeper on Bordetella pertussis toxin and adhesin virulence factors (None is universally used for the group as a whole. Specific members have abbreviations (e.g., PTX for pertussis toxin, FHA for filamentous hemagglutinin, PRN for pertactin, FIM for fimbriae), but there is no standard collective abbreviation.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bordetella pertussis toxin and adhesin virulence factors (None is universally used for the group as a whole. Specific members have abbreviations (e.g., PTX for pertussis toxin, FHA for filamentous hemagglutinin, PRN for pertactin, FIM for fimbriae), but there is no standard collective abbreviation.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call